https://health-union.com/wp-content/uploads/2023/01/HU-featured-image-Press-Release-012523.jpg
840
2202
Stephen Wilson
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Stephen Wilson2023-01-26 10:20:312023-05-04 09:46:17Understanding Rare Conditions: The Multifaceted Financial ImpactHealth Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.
https://health-union.com/wp-content/uploads/2023/01/HU-featured-image-Press-Release-012523.jpg
840
2202
Stephen Wilson
https://health-union.com/wp-content/uploads/2025/01/hu-higher-res-logo-2.png
Stephen Wilson2023-01-26 10:20:312023-05-04 09:46:17Understanding Rare Conditions: The Multifaceted Financial Impact
Bringing Patient Centricity to Life: Health Union’s Social Health Network

Patient and Caregiver Perspectives: How Pharma Can Improve the Chronic Condition Experience

Understanding Rare Conditions: Support & Connection
HCPs Important Factor for Clinical Trial Participation
Healthcare professionals can be influential in a patient’s clinical trial participation, but the impact is more nuanced and multifaceted.
Long-Term Business Vision: Importance for Growth
Many digital health companies are driven financially by short-term gains. Read why that’s less impactful than following a long-term business vision.
WHITEPAPER: Patient Interest and Participation in Clinical Trials
Health Union compiled data from more than 21,000 respondents to examine factors involved in patients’ interest and participation in clinical research.
Biologic Usage and Psoriasis Patients: What’s the barrier?
Many people living with psoriasis still do not use biologics, but those who do show greater HCP satisfaction and condition control.
Contact
1218 Chestnut St., 3rd Floor
Philadelphia, PA 19107
Phone: 484-985-9715
Fax: 484-450-2513
![]()
Privacy Notice
Terms of Use
Your Privacy Choices ![]()
Join Our Team
Press Kit




